We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
(+14%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
9.66%
Top 10 Holdings %
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$197M |
| 2 |
Alibaba
BABA
|
+$190M |
| 3 |
Amazon
AMZN
|
+$161M |
| 4 |
GoDaddy
GDDY
|
+$135M |
| 5 |
Walt Disney
DIS
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 2 |
Zoetis
ZTS
|
+$96.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$69.5M |
| 4 |
Cadence Design Systems
CDNS
|
+$64.2M |
| 5 |
ANSS
Ansys
ANSS
|
+$60.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.88% |
| 2 | Consumer Discretionary | 23.99% |
| 3 | Technology | 11.1% |
| 4 | Financials | 8.14% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$43.2B
| $14M | 0.12% |
+153,200
| New | +$13.8M |
|
202
Rio Tinto
RIO
$149B
| $13.9M | 0.11% |
223,011
+216,335
| +3,240% | +$13M |
|
203
PUT
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.9B
| $13.8M | 0.11% |
+233,600
| New | +$13.7M |
|
204
Herc Holdings
HRI
$4.95B
| $13.8M | 0.11% |
301,289
+49,796
| +20% | +$2.07M |
|
205
Verisk Analytics
VRSK
$27.8B
| $13.7M | 0.11% |
+93,514
| New | +$13.2M |
|
206
CONMED
CNMD
$1.33B
| $13.6M | 0.11% |
159,433
-239,289
| -60% | -$19.7M |
|
207
Korn Ferry
KFY
$4.26B
| $13.6M | 0.11% |
340,299
-25,974
| -7% | -$1.18M |
|
208
Linde
LIN
$236B
| $13.6M | 0.11% |
67,861
+36,473
| +116% | +$6.82M |
|
|
XYZ
209
Block Inc
XYZ
$49.5B
| $13.5M | 0.11% |
185,843
+132,467
| +248% | +$9.25M |
|
|
GRFS
210
Grifois
GRFS
$5.44B
| $13.4M | 0.11% |
634,051
+500,553
| +375% | +$9.55M |
|
211
PUT
iShares Russell 2000 ETF
IWM
$80.4B
| $13.3M | 0.11% |
+88,300
| New | +$13.6M |
|
212
PUT
iShares MSCI EAFE ETF
EFA
$76.8B
| $13.2M | 0.11% |
+210,200
| New | +$13.8M |
|
213
Golar LNG
GLNG
$4.95B
| $13.2M | 0.11% |
713,148
+407,606
| +133% | +$7.75M |
|
214
CALL
iShares MSCI Brazil ETF
EWZ
$9.13B
| $13.1M | 0.11% |
+302,200
| New | +$12.5M |
|
215
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.5B
| $13.1M | 0.11% |
105,103
-26,186
| -20% | -$3.14M |
|
216
Enanta Pharmaceuticals
ENTA
$367M
| $13M | 0.11% |
153,786
+9,333
| +6% | +$840K |
|
217
Affiliated Managers Group
AMG
$9.78B
| $13M | 0.11% |
+140,754
| New | +$13.8M |
|
218
CALL
State Street Technology Select Sector SPDR ETF
XLK
$112B
| $12.9M | 0.11% |
+325,200
| New | +$12.4M |
|
219
State Street Utilities Select Sector SPDR ETF
XLU
$23.4B
| $12.8M | 0.11% |
430,750
+125,366
| +41% | +$3.68M |
|
220
Evolent Health
EVH
$421M
| $12.8M | 0.11% |
1,613,272
+844,888
| +110% | +$10M |
|
221
Medpace
MEDP
$15.9B
| $12.7M | 0.1% |
194,737
+193,060
| +11,512% | +$11.1M |
|
|
222
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$43.2B
| $12.7M | 0.1% |
+138,300
| New | +$12.4M |
|
223
Textron
TXT
$15.6B
| $12.6M | 0.1% |
237,842
+230,389
| +3,091% | +$11.7M |
|
224
Orthofix Medical
OFIX
$496M
| $12.6M | 0.1% |
238,332
+84,747
| +55% | +$4.51M |
|
225
Robert Half
RHI
$4.04B
| $12.6M | 0.1% |
220,467
+77,309
| +54% | +$4.61M |
|
Similar funds
Marshall Wace's Q2 2019 Portfolio in Review
As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.
- Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
- Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
- Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
- Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
- Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
- Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.
Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.